FY26 B5 trinity biotech hemo analyzer QTR 1 BPC against FSS BPA for (2) two hemoglobin A1C analyzers, including all clinical material and required service for the U.S. Medical center for federal…

Ended Awarded Last action

Contract number
15B41426F00000031
Awardee
Awarding agency
Obligated
$11,700

Award facts

Contract value 100% obligated
$11,700.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Jamestown, NY 14701, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The U.S. Medical Center for Federal Prisoners in Springfield, Missouri, awarded a $11.7K firm fixed-price call against the General Services Administration Federal Supply Schedule contract to Biopool U.S., Inc. (doing business as Trinity Biotech Distribution) for two hemoglobin A1c analyzers, including all clinical materials and required service support. The award was issued on October 1, 2025, with an ultimate completion date of December 31, 2025, and utilized no set-aside designation, indicating full and open competition. Biopool U.S., Inc., a subsidiary of Irish-based Trinity Biotech PLC and located in Jamestown, New York, is a foreign-owned manufacturer and distributor of clinical laboratory diagnostics equipment that specializes in providing medical testing solutions to federal agencies.

This contract call was made under the Critical Analyzers, Laboratory Federal Supply Schedule contract (FSS-66-III), one of several significant indefinite delivery vehicles through which Biopool U.S., Inc. provides medical diagnostic products and services across the federal government. The company has established itself as a key supplier to multiple agencies including the Department of Veterans Affairs, Defense Logistics Agency, and the Medical Center for Federal Prisoners, with previous contract values ranging from modest procurements to over $119K. The hemoglobin A1c analyzers and associated clinical materials delivered under this award support the federal prison healthcare system's laboratory testing capabilities for diabetes and glycemic control monitoring.

Description

FY26 B5 trinity biotech hemo analyzer QTR 1 BPC against FSS BPA for (2) two hemoglobin A1C analyzers, including all clinical material and required service for the U.S. Medical center for federal prisoners, springfield, MO

Quick answers

Who was awarded contract 15B41426F00000031?

15B41426F00000031 was awarded to Biopool U.s., Inc. by Medical Center for Federal Prisoners Springfield (Correctional Facilities) on October 1, 2025.

How much is contract 15B41426F00000031 worth?

The government has obligated $11,700 on 15B41426F00000031.

Is contract 15B41426F00000031 an order under another contract?

Yes. 15B41426F00000031 is a BPA call under V797D40089-15B41423A00000036, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 15B41426F00000031 competed?

The extent of competition for 15B41426F00000031 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award